PharmaLegacy provides speed and translational confidence for analgesics pipelines by offering immediate study initiation in our extensively validated models of postoperative pain. Our multi-species capability ensures translational relevance, providing robust efficacy data across different metabolic and physiological systems, de-risking clinical translation.

Leverage PharmaLegacy’s deep familiarity with pain models and all analgesic classes (nonopioid, opioid, and adjuvant) to shorten your development timelines, generate a more robust and predictive data package, and advance your novel pain therapeutics.